LEO Pharma is seeking an ideal partner for its drug dersimelagon, which targets precision oncology, through potential acquisitions and MOUs.
1 report, 1 independent
Updated Aug 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
LEO Pharma is seeking an ideal partner for its drug dersimelagon, which targets precision oncology, through potential acquisitions and MOUs.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
LEO Pharma
international pharmaceutical company, based in Denmark
Nothing else this week.